Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Plos One|September 26, 2013
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patientsJoseph Saliba, Sofiane Hamidi, Gaëlle Lenglet, et al.
Blood Cancer Journal|July 9, 2023
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2<sup>V617F</sup> myeloproliferative neoplasmsCharly Courdy, Loïc Platteeuw, Charlotte Ducau, et al.
Blood|December 16, 2015
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutantsIlyas Chachoua, Christian Pecquet, Mira El-Khoury, et al.
Cell|March 3, 2015
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligandsIgnacio Moraga, Gerlinde Wernig, Stephan Wilmes, et al.
Ejhaem|August 21, 2023
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakesChristophe Willekens, Claude Chahine, Matteo Dragani, et al.
Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.
Blood|March 24, 2019
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutantsChristian Pecquet, Ilyas Chachoua, Anita Roy, et al.
The Journal of Clinical Investigation|February 28, 2017
Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosisLaure Gilles, Ahmet Dirim Arslan, Christian Marinaccio, et al.
Blood|October 10, 2015
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patientsXénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.
Blood|July 8, 2011
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitorsElodie Pronier, Carole Almire, Hayat Mokrani, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Plos One|September 26, 2013
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patientsJoseph Saliba, Sofiane Hamidi, Gaëlle Lenglet, et al.
Blood Cancer Journal|July 9, 2023
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2<sup>V617F</sup> myeloproliferative neoplasmsCharly Courdy, Loïc Platteeuw, Charlotte Ducau, et al.
Blood|December 16, 2015
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutantsIlyas Chachoua, Christian Pecquet, Mira El-Khoury, et al.
Cell|March 3, 2015
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligandsIgnacio Moraga, Gerlinde Wernig, Stephan Wilmes, et al.
Ejhaem|August 21, 2023
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakesChristophe Willekens, Claude Chahine, Matteo Dragani, et al.
Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.
Blood|March 24, 2019
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutantsChristian Pecquet, Ilyas Chachoua, Anita Roy, et al.
The Journal of Clinical Investigation|February 28, 2017
Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosisLaure Gilles, Ahmet Dirim Arslan, Christian Marinaccio, et al.
Blood|October 10, 2015
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patientsXénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.
Blood|July 8, 2011
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitorsElodie Pronier, Carole Almire, Hayat Mokrani, et al.
Pageof 13